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Target Organs in Chronic Bioassays of 533
Chemical Carcinogens
by Lois Swirsky Gold,* Thomas H. Slone,* Neela B.
Manley,* and Leslie Bernsteint
Acompendium ofcarcinogenesis bioassayresultsorganizedbytargetorganispresentedfor533chemicals
that are carcinogenic in at least one species. This compendium is based primarily on experiments in rats
or mice; results in hamsters, nonhuman primates, and dogs are also reported. The compendium can be
used to identify chemicals that induce tumors at particular sites, and to determine whether target sites
are the same forchemicals positive in morethanonespecies. TheCarcinogenic PotencyDatabase (CPDB),
which includes results of3969 experiments, is used in the analysis. The published CPDB includes details
on each test, and literature references. Chemical carcinogens are reported for 35 different target organs
in rats or mice. More than 80o ofthe carcinogens in each ofthese species are positive in at least one of
the 8 most frequent target sites: liver, lung, mammary gland, stomach, vascular system, kidney, hema-
topoietic system, andurinarybladder. Ananalysis ispresentedofhowwellonecanpredictthecarcinogenic
response in mice from results in rats, or vice versa. Among chemicals tested in both species, 76% of rat
carcinogens are positive in mice, and 71% of mouse carcinogens are positive in rats. Prediction is less
accurate to the same target site: 52% of rat carcinogens are positive in the same site in mice, and 48% of
mouse carcinogens are positive in the same site in rats. The liver is the most frequent site in common
between rats and mice.
Introduction
For a variety ofresearch purposes, a compendium of
carcinogenesis bioassay results organized by target or-
gan is useful. A single resource that lists all test agents
shown to induce tumors in a given species at each site
can facilitate investigations of particular site-specific
carcinogens, as well as comparisons ofresults in differ-
ent species. This paper presents such a resource doc-
ument (Table 1) based on the results of chronic, long-
termexperiments reported inthe Carcinogenic Potency
Database (CPDB). Several analyses of patterns of tar-
get sites in rats and mice are also presented.
The CPDB, in addition to providing an index of car-
cinogenic potency (1-4), is an exhaustive source of in-
formation on many aspects of bioassay design and re-
sults for 3969 species and sex-specific experiments on
1052 chemicals. The CPDB has been published in plot
format in four papers in Environmental Health Per-
spectives. Used in combination, the published plots of
the CPDB andthecompendiumbytarget organinTable
1, together provide comprehensive detailed results on
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each experiment including tumor pathology and inci-
dence rates, sex and strain tested, dose rates, shape of
the dose-response curves, statistical significance ofthe
slope ofthe dose-response curve, carcinogenic potency,
author's opinion about carcinogenicity, and literature
reference. As aresource, thecompendiuminthispaper,
organized by target organ, will be useful for a variety
of research endeavors. For example, epidemiologists
interested in a particular target tissue in humans may
seek clues in animal models, and can use the compen-
dium to obtain a list of substances found to induce tu-
mors at the site of interest in rats, mice, hamsters,
nonhuman primates, or dogs. Investigators interested
in mechanism ofcarcinogenesis at a specific target site,
or in chemical structure, can identify compounds that
induce tumors at that target organ. As one feature of
our summary table, we have indicated the carcinogens
at each target site that have been tested in both rats
and mice (by far the two most frequently used test
animals), and that are positive in both versus only one
of these species. Thus, comparative toxicologists can
determine whethera chemicalthatispositive at agiven
site in the rat has been tested in the mouse and if so,
whether it is positive in the mouse, and whether the
target organ(s) is the same.
This paper also summarizes the number ofchemicals
that induce tumors at each site in rats and mnice, and
compares the common tumor sites in the two species.GOLD ET AL.
Many chemicals cause tumors at more than one site in
a species (here termed "multiple-site carcinogens"), and
we describe the frequency withwhichthis occursinrats
and mice. In earlier work we examined the issue of
extrapolation between species by assessing how well
one can predict carcinogenicity from a rat to a mouse
or from a mouse to a rat (5). We showed that a variety
of factors affect the accuracy of prediction including
chemical class, mutagenicity, toxicity of the chemical
(measured by the administered high dose), and target
organ. In this paper we use additional results included
in the published CPDB for the subset of chemicals
tested in both rats and mice, to update data on the
frequency with which chemical carcinogens induce tu-
mors at the same site in rats and mice. In a separate
paper we will discuss the issue of mutagenicity of the
test agent and target organ (Gold et al., inpreparation).
Methods
Our analyses are based on the CPDB, which includes
results of chronic exposure animal bioassays that were
published either in the general literature through 1986
orinTechnicalReportsofthe NationalCancerInstitute/
National Toxicology Program (NCI/NTP) throughJune
1987 (1-4). All experiments in the CPDB meet a set of
inclusion criteria that were designed to allow for esti-
mation of carcinogenic potency; therefore, reasonable
consistency in experimental protocols is assured. Ex-
periments are included only if the test agent was ad-
ministered alone rather than in combination with other
substances; if the protocol included a control group, if
the route of administration was either diet, water, ga-
vage, inhalation, IV injection or IP injection; and ifthe
length ofthe experiment in rodents was at least 1 year
with dosing for at least 6 months. For the CPDB, evi-
dence for carcinogenicity in an experiment is based on
the evaluation ofthe published author; however, in ad-
dition, the statistical significance of the tumorigenic
dose-response is calculated and reported for each tissue
and tumor in the database (1). Some test agents are
excluded from the CPDB because the route of admin-
istration was not one of those defined above (for ex-
ample, some polycyclic aromatic hydrocarbons and in-
organic chemicals) and some because they are chemical
mixtures, particulates, or industrial processes. Among
the 241 chemicals, mixtures, and particulates that have
been evaluated by the International Agency for Re-
search on Cancer (IARC) as having sufficient evidence
for carcinogenicity in experimental animals (6,7), the
CPDB includes data on 64%.
In the analyses below, we classify a target organ as
positive on the basis ofthe author's opinion in the pub-
lished paper. Experiments evaluated as "inadequate"
by NCI/NTP are excluded. In some cases authors do
notclearly statetheirevaluation, andinsome NCI/NTP
Technical Reports the evidence for carcinogenicity at a
site is considered only "associated" with compound
administration or "equivocal"; in our analyses we con-
sider these experiments as lacking positive evidence of
carcinogenicity. For NTP reports, the evaluations of
"clear" or "some evidence" of carcinogenicity are both
classified as positive, as they are by NTP. We use the
author's opinion to determine positivity for an experi-
ment because, in addition to statistical significance, it
often takes into account historical control rates for par-
ticular sites, poor survival, tumor latency, and/or dose
response. Positive target sites for a chemical are iden-
tified across experiments in a species using all results
forachemicalfromboththegeneralliterature and NCI/
NTPbioassays. Hence, ifachemicalhastwotargetsites
in a species, the results may represent two different
experiments, although this occurs infrequently.
ThecompendiuminTable 1 includesthe533chemicals
in the CPDB that are positive in at least one site in one
test ofone species, regardless ofthe number oftests in
the database. In the CPDB, the number ofexperiments
per chemical varies and some chemicals are more thor-
oughly tested than others. Among all chemicals in the
CPDB, the percentages with one experiment, two ex-
periments, and more than two experiments are 30%,
52%, and 18%, respectively, forrats and 12%, 56%, and
32%, respectively, formice. The specific histopathology
associated with each target site is not presented in this
compendium but is reported in the published plots of
the database using the nomenclature ofthe original au-
thor (1-4). The original reference of each experiment
is listed under the chemical name on the right side of
the plot ofthe CPDB and in the bibliography (1-4).
One feature of the CPDB is the inclusion of experi-
ments with species other than rats and mice. Among
the results reported in the compendium (Table 1) are
those for 36 carcinogens in hamsters, 8 in nonhuman
primates [aflatoxin B1, methylazoxymethanol acetate
and cycasin mixture, 2-naphthylamine, N-nitroso-N-
methylurea, N-nitrosodiethylamine, N-nitrosopiperi-
dine, procarbazine.HCl, and urethane], and 2 in dogs
[3,3'-dichlorobenzidine and4,4'-methylene-bis(2-chloro-
aniline)].
Description of Table 1:
Carcinogenic Response by Target
Organ for 533 Chemical
Carcinogens
Table 1 lists all chemicals in the CPDB that induce
tumors in each of 35 target organs in rats, mice, ham-
sters, monkeys, prosimians, or dogs. The table is or-
ganized alphabetically by site, species, and chemical.
This compendium permits comparisonsbetween species
at agiventargetsite; forexample, ifkidneyisthetarget
organ of interest, a list of kidney carcinogens ordered
alphabetically for each species is presented: 1 chemical
in the monkey, 12 in the mouse, and 45 in the rat.
Because we have indicated with superscripts those
chemicals that have been tested in both rats and mice,
it is possible to see whetherthe kidneyis atarget organ
in both species for a given chemical. For example, for
the rat kidney, chloroform is listed with the symbol t
(text continues on page 241)
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Table 1. Carcinogenic response by target organ for 533 chemicals classified as positive by author's opinion. A chemical is listed under each organ that is
evaluated as positive in an experiment in that species by at least one author. Therefore, a chemical may be listed under several target organs and every chemical listed in the table is
positive in at least one species. In order to compare results in rats and mice, the two most commonly tested species, symbols are applied to chemicals tested in both species. A t indicates
that the chemical is positive at some site in both species, and a t indicates that it was tested in both but positive in only one. Detailed information on each experiment is presented in the
four published plots of the Carcinogenic Potency Database. N = the number of chemicals with at least one positive test at that site in that species.
Tissue Species N Chemical names
Adrenal Hamster 1 urethaneT
gland Mouse 4 carbon tetrachloridet; 4,4-methylenedianiline.2HClt;p-rosaniline.HC1A; 1,1,2-trichloroethanet
Rat 7 acrylamide; 4-chloro-m-phenylenediaminet; 1,2-dibromo-3-chloropropanet,a; diethylstilbestrolt,a; ethyl
alcohol; 1,2-propylene oxidet; reserpinet
Bone Monkey 2 aflatoxin B,t; procarbazine.HC/t
Rat 3 acronycine; 1-(2-hydroxyethyl)-l-nitrosourea; o-toluidine.HC1-
Central nervous Mouse 2 N-nitrosodimethylaminet; procarbazine.HC/t
system Rat 15 acrylamide; acrylonitrile; 2-amino-6-methyldipyrido[1,2-a:3',2'-dlimidazolet; 2-aminodipyrido[1,2-
a:3',2'-dJimidazolet; chlorambucilt; 1-(4-chlorophenyl)-l-phenyl-2-propynyl carbamate; cyclophos-
phamidet; l-ethyl-l-nitrosourea; ethylene oxide; R(-)-2-methyl-N-nitrosopiperidine; S(+)-2-methyl-N-
nitrosopiperidine; I-phenyl-3,3-dimethyltriazene; procarbazine.HC1A; propane sultone; vinyl chloridet
Clitoral Mouse 2 acetaldehyde methylformylhydrazone; N-N-butyl-N-formylhydrazine
gland Rat 7 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazolet; 2-amino-3-methylimidazo[4,5-JAquinolinet; 2-amino-
dipyrido[1,2-a:3',2':dJimidazolet; 2,4-diaminoanisole sulfatet; 1,5-naphthalenediaminet; 5-nitro-o-
anisidinet; 5-nitroacenaphthenei
Ear/Zymbal's Mouse 2 benzenet; cupferront
gland Rat 30 acrylonitrile; 3-amino-9-ethylcarbazole.HCIt; 2-amino-6-methyldipyrido[ 1,2-a:3',2'-dlimidazolet; 2-
amino-3-methylimidazo[4,5-Aquinolinet; 2-amino-3-methylimidazo[4,5-Aquinoline.HCl; 2-aminodipy-
rido[1,2-a:3',2'-dJimidazolet; benzenet; N-N-butyl-N-nitrosourea; chlorambucilt; cupferront; N-l-diacet-
amidofluorene; 2,4-diaminoanisole sulfatet; 3,3'-dichlorobenzidine; 2,5-dimethoxy-4'-aminostilbenet; N-
(2-fluorenyl)-2,2,2-trifluoroacetamide; formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazidet; hydrazo-
benzenet; 2-methoxy-3-aminodibenzofuran; N-(N-methyl-N-nitrosocarbamoyl)-l-ornithine; 4,4'-
methylene-bis(2-chloroaniline); 5-nitro-*oanisidinet; 5-nitroacenaphthenet; N-(9-oxo-2-fluorenyl) acet-
amide; phenacetint; prednimustine; p-rosaniline.HCIt; thio-TEPAt; 4,4'-thiodianilinet; f.-thioguanine de-
oxyriboside; vinyl chloridet
Esophagus Hamster 2 AF-2t; N-nitroso-N-methylurethan
Monkey 2 methylazoxymethanol acetate and cycasin mixture; N-nitroso-N-methylurea
Mouse 7 benzo(a)pyrenet; 1,2-dibromoethanet; N-ethyl-N-nitro-N-nitrosoguanidine; N-hydroxy-2-acetylamino-
fluoreneT; 3-(5-nitro-2-furyl)-imidazo( 1,2-a)pyridinet; nitrosodibutylaminet; N-nitrosohexamethylene-
imine
Rat 29 N-N-butyl-N-nitrosourea; dihydrosafrolet; dimethylvinyl chloridet; dinitrosohomopiperazine; Z-ethyl-
O,N,N-azoxyethane; 3-(5-nitro-2-furyl)-imidazo( 1,2-a)pyridinet; N-nitroso-2,3-dihydroxypropyl-2-
hydroxypropylamine; nitroso-2,3-dihydroxypropyl-2-oxopropylamine; N-nitroso-(2-hydroxypropyl)-(2-
hydroxyethyl) amine; N-nitroso-N-methyl-4-fluoroaniline; nitroso-N-methyl-N-(2-phenyl) ethylamine;
nitroso-1,2,3,6-tetrahydropyridine; N-nitroso(2,2,2-trifluoroethyl) ethylamine; N-nitrosoallyl-2,3-di-
hydroxypropylamine; N-nitrosoallyl-2-hydroxypropylamine; N-nitrosoallyl-2-oxopropylamine; nitroso-
amylurethan; nitrosoanabasine; N-nitrosobis(2-hydroxypropyl) amine; N-nitrosodiethanolamine; N-
nitrosodiethylamine; N-nitrosodipropylamine; nitrosoheptamethyleneimine; N-nitrosomethyl-2,3-di-
hydroxypropylamine; N-nitrosomethyl-2-hydroxypropylamine; 2-nitrosomethylaminopyridine; nitroso-
methylaniline; N-nitrosonornicotine-l-N-oxide; N-nitrosothiomorpholine
Gall Hamster 1 N-methyl-N-formylhydrazine
bladder Monkey 1 aflatoxin B t
Mouse 3 N-ethyl-N-f?ormylhydrazine; N-methyl-N-formylhydrazine; N-N-propyl-N-formylhydrazine
Harderian gland Mouse 6 benzenet; benzidine.2HCI; cupferront; dichloroacetylenet; gentian violet; 4,4-oxydianilinet
Hematopoietic Monkey 1 procarbazine.HCdt
system
Mouse 39 acetamidet; aflatoxin, crudet; allyl isovaleratet; trans-5-amino-3[2-(5-nitro-2-furyl)vinyl- 1,2,4-oxadi-
azole; 2-amino-4-(p-nitrophenyl) thiazole; 2-aminoanthraquinonet; benzenet; benzoyl hydrazine; 1,3-
butadiene; 1,2-di-N-butylhydrazine.2HCl; chlorambucilt; chlorinated paraffins (C23, 43% chlorine)t;
cyclophosphamidet; dacarbazinet; DDTt; dibromodulcitolt; dibromomannitolt; estradiol mustardt;
formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazidet; gentian violet; hexanamidet; 2-hydrazino-4-(p-
aminophenyl) thiazolet; 2-hydrazino-4-(p-nitrophenyl) thiazolet; ICRF-159t; isophosphamidet; mel-
phalant; 1-methyl-1,4-dihydro-7-[2-(5-nitrofuryl)vinyl]-4-oxo-1,8-naphthyridine-3-carboxylate, potas-
sium; methyl methanesulfonate; 4,4'-methylenedianiline.2HCOt; metronidazolet; N-[4-(5-nitro-2-furyl)-
2-thiazolyl]formamidet; phenesterint; phorbol; procarbazine.HCIt; strobane; thio-TEPAt; p-tolylureat;
urethane; C.I. Vat Yellow 4t
(Continued on next page)
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Table 1. Continued.
Tissue Species N Chemical names
Rat 35 allyl isovalerateT; 1-amyl-l-nitrosourea; benzidine; N-N-butyl-N-nitrosourea; chlorambucilT; cyclophos-
phamidet; dacarbazine; 1,3-dibutyl-1-nitrosourea; dichloroacetylenet; 3,3-dichlorobenzidine; dimeth-
oxane; 3,3-dimethoxybenzidine-4,4-diisocyanatet; 2-(2,2-dimethylhydrazino)-4-(5-nitro-2-furyl) thia-
zole; dimethyl morpholinophosphoramidatet; ethylene oxide; formic acid 2-[4-(5-nitro-2-furyl)-2-thia-
zolyl]hydrazidet; FD & C Green No. It; FD & C Green No. 2t; hematoxylin; 2-hydrazino-4-(p-amino-
phenyl) thiazolet; 1-(2-hydroxyethyl)-l-nitrosourea; lasiocarpine; metepa; 1-5-morpholinomethyl-3-[(5-
nitrofurfurylidene)amino]-2-oxazolidinone.HCl; nitrite, sodiumt; N-[5-(5-nitro-2-furyl)-1,3,4-thiadi-
azol-2-yl]acetamidet; 1-[(5-nitrofurfurylidene)amino]-2-imidazolidinone; nitroso-N-methyl-N-(2-phenyl)
ethylamine; procarbazine.HCdt; propane sultone; FD & C Red No. 2; FD & C Red No. 4t; tetrachloro-
ethylenet; thio-TEPAt; 2,4,6-trichlorophenolt
Kidney Monkey I methylazoxymethanol acetate and cycasin mixture
Mouse 12 1,2-di-N-butylhydrazine.2HCI chloroform*; daminozidet; dichloroacetylenet; N-hydroxy-2-acetylamino-
fluorenet; lead acetate, basic4; nitrilotriacetic acidt; ochratoxin At; phenacetint; streptozotocint; tris-
(2,3-dibromopropyl) phosphatet; vinylidene chloridet
Rat 45 aflatoxin B1t; I-amino-2-methylanthraquinonet; 2-amino-5-(5-nitro-2-furyl)-1,3,4-oxadiazole; 2-amino-
5-(5-nitro-2-furyl)-1,3,4-thiadiazole; 2-amino-5-nitrothiazolet; o-anisidine.HC1; azoxymethane; bromate,
potassiumt; chlorinated paraffins (Cl2, 60% chlorine)t; chloroformt; chlorothalonilT; cinnamyl anthra-
nilatet; citrinin; dichloroacetylenet; 1,4-dichlorobenzenet; diethylacetamide; dimethoxane; 4,6-di-
methyl-2-(5-nitro-2-furyl) pyrimidine; N-4-(4-fluorobiphenyl) acetamide; formic acid 2-[4-(5-nitro-2-
furyl)-2-thiazolyl]hydrazidet; hexachlorobutadiene; hexamethylmelamine; 2-hydrazino-4-(5-nitro-2-furyl)
thiazolet; isophoronet; lead acetatet; lead acetate, basict; 2-methoxy-3-aminodibenzofuran; Z-methyl-
O,N,N-azoxyethane; N-(N-methyl-N-nitrosocarbamoyl)-l-ornithine; 1-5-morpholinomethyl-3-[(5-nitrofur-
furylidene)aminoJ-2-oxazolidinone.HCI; nitrilotriacetic acidi; nitrilotriacetic acid, trisodium salt,
monohydratet; 3-(5-nitro-2-furyl)-imidazo( 1,2-a)pyridinet; N-([3-(5-nitro-2-furyl)-1,2,4-oxadiazole-5-yl]-
methyl)acetamide; N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazol-2-yl]acetamidet; 1-nitroso-1-hydroxyethyl-3-
chloroethylurea; N-nitrosodiethanolamine; N-oxydiethylene thiocarbamyl-N-oxydiethylene sulfenamide;
phenacetint; phenazone; o-phenylphenate, sodiumt; streptozotocint; tetrachloroethylenet; tris(2,3-di-
bromopropyl) phosphatet; vinyl chloridet
Large intestine Hamster 5 1,l-dimethylhydrazine; 1,2-dimethylhydrazine.2HCI; hydrazinet; methylhydrazine; urethanet
Rat 15 aflatoxin B t; 2-amino-6-methyldipyrido[1,2-a:3',2'-dlimidazolet; 2-amino-3-methylimidazo[4,5-JAquin-
olinet; 2-aminodipyrido[1,2-a:3',2'-dlimidazolet; amylopectin sulfate; azoxymethane; carrageenan, acid-
degraded; chrysazint; dextran sulfate sodium (DS-M-1); Z-ethyl-O,N,N-azoxymethane; formic acid 2-[4-
(5-nitro-2-furyl)-2-thiazolyl]hydrazidet; N-nitrosobis(2-oxopropyl) amine; phenazopyridine.HClt; 4,4'-
thiodianilinet; tris(2,3-dibromopropyl) phosphatet
Liver Bush baby 1 N-nitrosodiethylamine
Dog 2 3,3-dichlorobenzidine- 4,4'-methylene-bis(2-chloroaniline)
Hamster 14 2-acetylaminofluorenei; p,p-DDEt; 1,2-dimethylhydrazine.2HCI; hexachlorobenzenet; N-hydroxy-2-
acetylaminofluorenet; N-methyl-N-formylhydrazine; methylhydrazine; N-nitroso-1,3-oxazolidine;
nitroso-2-oxopropylethanolamine; N-nitrosoallyl-2-oxopropylamine; N-nitrosoazetidine; N-nitroso-
morpholine; N-nitrosopiperidinet; N-nitrosopyrrolidinet
Monkey 5 aflatoxin Bt methylazoxymethanol acetate and cycasin mixture; N-nitrosodiethylamine; N-nitroso-
piperidinet; urethanet
Mouse 171 acetaminophent; 2-acetylaminofluorene;; aldrin;; 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole acetatet;
2-amino-3,4-dimethylimidazo[4,5-Aquinoline; 3-amino-9-ethylcarbazole.HClA; 2-amino-3-methyl-9H-
pyrido-[2,3-b]-indole; 3-amino-l-methyl-5H-pyrido[4,3-b]indole acetatet; 1-amino-2-methylanthraauin-
onet; 2-amino-6-methyldipyrido[ 1,2-a:3',2-dlimidazolet- 2-amino-3-methylimidazo[4,5-JAquinolin ; 2-
amino-9H-pyrido(2,3-b) indole; 2-aminoanthraquinone4; 4-aminodiphenyl; 4-aminodiphenyl.HClt; 2-
aminodiphenylene oxide; 2-aminodipyrido[1,2-a:3',2:dlimidazolet; 3-aminotriazolet aramitet- aroclor
1254t; auramine-Ot; benzidine.2HCI; benzyl acetatet; bis(2-chloro-1-methylethyl) etheri; bis-2-
chloroethylether; bis-2-hydroxyethyldithiocarbamic acid, potassium; HC Blue No. 1$; 1,3-butadiene;
1,1-di-N-butylhydrazine; captafol; carbazole; carbon tetrachloridet; chlorambent; chlordanet; chlorendic
acids; chlorinated paraffins (C12, 60% chlorine)t; 1-chloro-2-nitrobenzenet; 1-chloro-4-nitrobenzenet; 4-
chloro-m-phenylenediamine; 4-chloro-o-phenylenediaminet; 5-chloro-*otoluidinet; [4-chloro-6-(2,3-
xylidino)-2-pyrimiduinylthio]acetic acids; 4-chloro-642,3-xylidino)-2-pyrimidinylthio(N-,3- hydroxy-
ethyl)acetamidet; chlorobenzilatet; chlorodibromomethanet; chloroform*; chrysazint; cinnamyl anthra-
nilatet; p-cresidine$; cupferront; cyclamate, sodiumt; cyclochlorotine; p,&f-DDDt; p,&-DDEt; DDTt; di-
allate; 2,4-diaminotoluenet; 2,4-diaminotoluene.2HClt; 3,5-dichloro(N-1,1-dimethyl-2-propynyl) ben-
zamide; 2,6-dichloro7p-phenylenediaminet; 1,4-dichlorobenzenet; 1,2-dichloropropanet; dicofolt; diel-
drint; diftalone; dihydrosafrolet; 2,5-dimethoxy-4-aminostilbenet; 1,1-dimethylhydrazine; 1,4-dioxanet;
dipyronet; estragole; DL-ethioninet; o-ethoxybenzamide; N-ethyl-N-formylhydrazine; ethylene imine;
ethylene thioureat; di(2-ethylhexyl) adipateT; di(2-ethylhexyl) phthalatet; 4-fluoro-4-aminodiphenyl;
gentian violet; griseofulvin; HCDD mixturet; heptachlort; hexachlorobenzenet; hexachlorocyclohexane;
a--1,2,3,4,5,6-hexachlorocyclohexanet; jl-1,2,3,4,5,6-hexachlorocyclohexane; -r1,2,3,4,5,6-hexachloro-
cyclohexanet; hexachloroethanet; hydrazine sulfatet; hydrazobenzenet; N-hydroxy-2-acetylamino-
fluorenet; i-hydroxyestragole; 2-hydroxyethylhydrazine; I-hydroxysafrolet; isoniazidt; keponet; leupep-
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Table 1. Continued.
Tissue Species N Chemical names
tin; luteoskyrin; malonaldehyde, sodium; 3-methoxy-4-aminoazobenzene; N-methyl-N-formylhydrazine;
4,4'-methylene-bis(2-chloroaniline).2HClt; methylene chloridet; 4,4'-methylenebis(N,N-dimethyl)
benzenaminet; 4,4-methylenedianifine.2HCAt; methylhydrazine; Michler's ketonet; mirext; 1,5-naph-
thalenediaminet; 2-naphthylaminet; nithiazidet; 3-nitro-p-acetophenetidet; 5-nitro-*oanisidinet; 2-nitro-
p-phenylenediaminet; 5-nitro-*otoluidinet; 5-nitroacenaphthenet; 6-nitrobenzimidazolet; nitrofent;
nitrosodibutylaminet; N-nitrosodimethylaminet; p-nitrosodiphenylaminet; N-nitrosohexamethylene-
imine; N-nitrosopiperidinet; ochratoxin At; 4,4'-oxydianilineT; pentachloroethanet; pentachloronitro-
benzenet; phenazopyridine.HCIt; phenobarbitalt; phenobarbital, sodiumt; o-phenylenediamine.2HClt;
piperonyl sulfoxidet; polybrominated biphenyl mixturet; N-N-propyl-N-formylhydrazine; D & C Red
No. 5t rifampicint; ripazepamt; p-rosaniline.HClt; safrolet; selenium diethyldithiocarbamate; selenium
sulfidet; strobane; 2,3,7,8-tetrachlorodibenzo-*pdioxint; 1,1,1,2-tetrachloroethanet; 1,1,2,2-tetrachloro-
ethanet; tetrachloroethylenet; tetrachlorvinphost; tetrafluoro-m-phenylenediamine.2HClt; thioacet-
amide; 4,4'-thiodianilinet; thiouracil; toluene diisocyanate, commercial grade (2,4 (80%)- and 2,6
(20%)-)t; m-toluidine.HClt; o-toluidine.HCI:; p-toluidine.HCIt; toxaphenet; 2,4,6-trichloroanilinet;
1,1 2-trichloroethanet; trichloroethylenet; 2,4,6-trichlorophenolt; trifluralint; 2,4,5-trimethylanilinet;
2,4,5-trimethylaniline.HCAt; 2,4,6-trimethylaniline.HC1t; tris(2,3-dibromopropyl) phosphatet; tris(2-
ethylhexyl) phosphatet; urethanet; 2,5-xylidine.HC1t; C.I. Disperse Yellow 3t; zearalenonet
Rat 143 acetamide; acetaminophen; acetoxime; 2-acetylaminofluorenel; aflatoxicol; aflatoxin B aflatoxin,
crudet; 3-amino-1,4-dimethyl-5H-pyrido[4,3-blindole acetatet; 3-amino-9-ethylcarbazole.HCl:; 3-
amino-1-methyl-5H-pyrido[4,3-b]indole acetatet; I-amino-2-methylanthraquinonet; 2-amino-6-methyldi-
pyrido[1,2-a:3',2-d]imidazolet; 2-amino-3-methylimidazo[4,5-AquinolineT; 2-amino-3-methylimidazo-
[4,5- quinoline.HCI; 2-aminoanthraquinonet; o-aminoazotoluenet; 2-aminodipyrido[1,2-a:3',2'-d]imid-
azole ; 11 -aminoundecanoic acidt; aramitet; aroclor 1260; auramine-Ot; azoxymethane; benzidine;
bromodichloromethane; carbon tetrachloridet; chlorendic acidt; chlorinated paraffins (C12, 60%
chlorine)t; 4-chloro-4'-aminodiphenylethert; 2-chloro-5-(3,5-dimethylpiperidinosulphonyl)benzoic acid;
[4-chloro-6-(2,3-xylidino)-2-pyrimidinylthiolacetic acid ; 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-
(N-fl-hydroxyethyl) acetamidet; chlorobenzenet; chlorobenzenet; chloroformt; ciprofibrate; clivorine;
clofibrate; clophen A 30; p-cresidinet; crotonaldehyde; cupferront; DDTt; decabromodiphenyl oxidet;
2,4-diaminotoluenet; 2,4-diaminotoluene.2HC[f; 1,2-dibromoethanet; dichloroacetylene- N,N-diethyl-
4-(4'-[pyridyl-1'-oxidejazo) aniline; dimethoxane; N,N-dimethyl-4-aminoazobenzene; dimethylnitramine;
dinitrosohomopiperazine; 1,4-dioxanet; ethionine; DL-ethioninet; ethyl alcohol; Z-ethyl-O,N,N-azoxy-
ethane; Z-ethyl-O,N,N-azoxymethane; ethylene thioureat; di(2-ethylhexyl) phthalatet; N-(2-fluorenyl)-
2,2,2-trifluoroacetamide; formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazidet; FD & C Green
No. It; HCDD mixturet; hexachlorobenzenet; a-1,2,3,4,5,6-hexachlorocyclohexanet; hydrazine sulfatet;
hydrazobenzenet; N-hydroxy-2-acetylaminofluorenet; F-hydroxysafrolet; isoniazidt; keponet; lasio-
carpine; methapyrilene.HCI; Z-methyl-O,N,N-azoxyethane; methyl clofenapate; 3'-methyl-4-dimethyl-
aminoazobenzene; 2-methyl-l-nitroanthraquinonet; 4-(4-N-methyl-N-nitrosaminostyryl) quinoline; 4,4'-
methylene-bis(2-chloroaniline); 4,4'-methylene-bis(2-methylaniline); 4,4'-methylenedianiline.2HC1t;
metronidazolet; Michler's ketonet; monocrotaline; nitrite, sodiumt; N-nitroso-bis-(4,4,4-trifluoro-N-
butyl) amine; 1-nitroso-5,6-dihydrouracil; N-nitroso-2,3-dihydroxypropylethanolamine; 1-nitroso-l -
hydroxyethyl-3-chloroethylurea; 1-nitroso-1-(2-hydroxypropyl)-3-chloroethylurea; N-nitroso-(2-hydroxy-
propyl)-(2-hydroxyethyl) amine; N-nitroso-N-methyl-N-dodecylamine; nitroso-N-methyl-N-(2-phenyl)
ethylamine; N-nitroso-N-methyldecylamine; nitroso-2-oxopropylethanolamine; nitroso-1,2,3,6-tetra-
hydropyridine; N-nitrosoallyl-2-hydroxypropylamine; N-nitrosoallyl-2-oxopropylamine; N-nitrosoallyl-
ethanolamine; N-nitrosobis(2-oxopropyl) amine; nitrosodibutylaminet; N-nitrosodiethanolamine; N-
nitrosodiethylamine; N-nitrosodimethylaminet; p-nitrosodiphenylaminet; N-nitrosodipropylamine;
nitrosododecamethyleneimine; N-nitrosoephedrine; nitrosoheptamethyleneimine; N-nitrosomethyl-2,3-
dihydroxypropylamine; nitrosomethylundecylamine; N-nitrosopyrrolidinet; o-nitrosotoluene; norlestrint;
N-(9-oxo-2-fluorenyl) acetamide; 4,4'-oxydianilinet; petasitenine; phenobarbital, sodiumt; I-phenylazo-
2-naphtholt; o-phenylenediamine.2HC1t; polybrominated biphenyl mixturet; pyrilamine maleate; D & C
Red No. 5t; D & C Red No. 9t; FD & C Red No. 1; p-rosanifine.HC/t; safrolet; selenium sulfidet; sen-
kirkine; sterigmatocystint; symphytine; Telone IIt; 3,3',4,4-tetraaminobiphenyl.4HC/t; 2,3,7,8-tetra-
chlorodibenzo-*pdioxint; 4,4-thiodianilinet; toluene diisocyanate, commercial grade (2,4 (80%)- and 2,6
(20%)-)t; 2,4,5-trimethylanilinet; 2,4,5-trimethylaniline.HClt; 2,4i,6-trimethylaniline.HClt; vinyl acetate;
vinyl bromide; vinyl chloridet; C.I. Disperse Yellow 3t
Tree shrew 1 aflatoxin B t
Lung Hamster 2 nitroso-2,6-dimethylmorpholine; 1-nitroso-3,4,5-trimethylpiperazine
Mouse 83 acetaldehyde methylformylhydrazone; N-acetyl-4-(hydroxymethyl) phenylhydrazine; I-acetyl-2-isonico-
tinoylhydrazine; allylhydrazine.HCl; 2-amino-3-methylimidazo[4,5-Aquinolinet arecoline.HCl; ben-
zenet- benzoyl hydrazine; benzylhydrazine.2HCI; bis(2-chloro-l-methylethyl) ethert; bis-(chloromethyl)
ether4; 1,3-butadiene; N-N-butyl-N-formylhydrazine; butylated hydroxytoluenet; 1,1-di-N-butylhydra-
zine; N-butylhydrazine.HCl; 1,2-di-N-butylhydrazine.2HCI; carbamyl hydrazine.HCI; l-carbamyl-2-
phenylhydrazine; chlorambucilt; cyclophosphamidet; dacarbazinet; daminozidet; p,p-DDDt; 1,1-diallyl-
hydrazine; 1,2-diallylhydrazine.2HCl; dibenz(a,h) anthracene; 1,2-dibromo-3-chloropropanet; dibromo-
dulcitolt; 1,2-dibromoethanet; dibromomannitol; 1,2-dichloroethanet; 1,2-diformylhydrazine; dihydro-
safrolet; 2,5-dimethoxy-4'-aminostilbenet; 1,l-dimethylhydrazine; 1,2-dimethylhydrazine.2HCl; estradiol
mustardt; N-ethyl-N-formylhydrazine; ethylene imine; ethylhydrazine.HCl; formylhydrazine; hydrazinet;
hydrazine sulfatet; isoniazidt; isonicotinic acid vanillylidenehydrazide; melphalant; l-methyl-l,4-di-
hydro-7-[2-(5-nitrofuryl)vinyl]-4-oxo-1,8-naphthyridine-3-carboxylate, potassium; N-methyl-N-formyl-
hydrazine; methyl methanesulfonate; methylene chloridet; methylhydrazine; methylhydrazine sulfate;
(Continued on next page)
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(N-6)-(methylnitroso) adenine; (N-6)-(methylnitroso) adenosine; metronidazolet; monoacetyl hydrazine;
1,5-naphthalenediaminet; nicotinic acid hydrazide; N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamidet; 3-
nitro-3-hexenet; nitrosodibutylaminet; N-nitrosodimethylaminet; N-nitrosopiperidinet; N-pentylhydra-
zine.HCI; phenesterint; phenylethylhydrazine sulfate; procarbazine.HC(t; N-N-propyl-N-formylhydra-
zine; propylhydrazine.HC1; selenium sulfidet; streptozotocint; sulfallatet; Telone IIt; 3,3',4,4-tetra-
aminobiphenyl.4HClt; trichloroethylenet; trifluralinT; 2,4,5-trimethylaniline.HCft; tris(2,3-dibromopro-
pyl) phosphatet; urethanet; vinyl chloridet; vinylidene chloridet; 2,4-xylidine.HC1t
Rat 31 2-amino-5-(5-nitro-2-furyl)-1,3,4-oxadiazole; 2-amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole; 2-amino-5-
nitrothiazolet; bis-(chloromethyl) ethert; HC Blue No. It; 1,2-dibromoethanet; dimethyl hydrogen phos-
phitet; trans-2-[(dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinylJ-1 ,3,4-oxadiazole; hydrazinet;
hydrazine sulfatet; 1-(2-hydroxyethyl)-l-nitrosourea; isoniazidt; 4,4'-methylene-bis(2-chloroaniline); N-
([3-(5-nitro-2-furyl)- 1 ,2,4-oxadiazole-5-yl]-methyl)acetamide; N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazol-2-yl]
acetamidet; 3-nitro-3-hexenet; 5-nitroacenaphthenet; N-nitroso-bis-(4,4,4-trifluoro-N-butyl) amine; N-
nitroso-N-methyl-N-dodecylamine; N-nitroso-N-methyl-N-tetradecylamine; N-nitroso-N-methyldecyl-
amine; N-nitrosobis(2-hydroxypropyl) amine; N-nitrosobis(2-oxopropyl) amine; nitrosodibutylaminet;
N-nitrosoephedrine; N-nitrosomethyl-2,3-dihydroxypropylamine; nitrosomethylundecylamine; 2,3,7,8-
tetrachlorodibenzo-p-dioxint; 2,4,5-trimethylanilinet; 2,4,6-trimethylaniline.HCAt; vinyl chloridet
Mammary Hamster 1 vinyl chloridet
gland Mouse 14 benzenet; 1,3-butadiene; 1,2-dibromoethanet; 1,2-dichloroethanet; diethylstilbestrolt; estradiol; iso-
niazidt; isonicotinic acid vanillylidenehydrazide; (N-6)-(methylnitroso) adenosine; reserpinet; sulfallatet;
vinyl chloridet; vinylidene chloridet; vitamin D2
Rat 73 4-acetylaminobiphenyl; 2-acetylaminofluorenet; acronycine; acrylamide; acrylonitrile; AF-2t; 2-amino-
3-methylimidazo[4,5-Aquinoline.HC1; 2-amino-5-(5-nitro-2-furyl)-1,3,4-oxadiazole; 2-amino-5-(5-nitro-
2-furyl)- 1,3,4-thiadiazole; 2-amino-5-nitrothiazolet; 4-aminodiphenyl.HC1A;l-amyl-l-nitrosourea; benzi-
dine; 4-bis(2-hydroxyethyl)amino-2-(5-nitro-2-thienyl) quinazoline; carbon tetrachloridet; carboxy-
methylnitrosourea; chlorambucilt; cytembenat; dacarbazinet; N-1-diacetamidofluorene; 4,6-diamino-2-
(5-nitro-2-furyl)-S-triazine; 2,4-diaminoanisole sulfatet; 2,4-diaminotoluenet; 1,2-dibromo-3-chloro-
propanet; 1 ,2-dibromoethanet; dibromomannitolt; 1 ,3-dibutyl- l-nitrosourea; 3,3'-dichlorobenzidine;
1,2-dichloroethanet; 4,6-dimethyl-2-(5-nitro-2-furyl) pyrimidine; 1,2-dimethyl-5-nitroimidazole; trans-2-
[(dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]- 1,3,4-oxadiazole; 2-(2,2-dimethylhydrazino)-
4-(5-nitro-2-furyl) thiazole; N-(2-fluorenyl)-2,2,2-trifluoroacetamide; formic acid 2-(4-methyl-2-thiazolyl)
hydrazide; formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolylJhydrazidet; hexamethylmelamine; 2-hydrazino-
4-(p-aminophenyl) thiazolet; 2-hydrazino-4-(5-nitro-2-furyl) thiazolet; 2-hydrazino-4-(p-nitrophenyl) thi-
azolet; hydrazobenzenet; 1-(2-hydroxyethyl)-3-[(5-nitrofurfurylidene)amino]-2-imidazolidinone; iso-
niazidt; 2-methoxy-3-aminodibenzofuran; 4-methyl- 1-[(5-nitrofurfurylidene)amino]-2-imidazolidinone;
N-(N-methyl-N-nitrosocarbamoyl)-l-ornithine; 3-methylcholanthrene; 4,4'-methylene-bis(2-chloroaniline);
4,4'-methylene-bis(2-methylaniline); methylene chloridet; metronidazolet;1-5-morpholinomethyl-3-[(5-
nitrofurfurylidene)amino]-2-oxazolidinone.HC/; nithiazidet; 5-nitro-2-furaldehyde semicarbazone; 3-(5-
nitro-2-furyl)-imidazo( 1 ,2-a)pyridinet; 4-(5-nitro-2-furyl) thiazole; N-[4-(5-nitro-2-furyl)-2-thia-
zolyl]acetamide; N,N[6-(5-nitro-2-furyl)-S-triazine-2,4-diyl]bisacetamide; 5-nitroacenaphthene 1-5-
nitrofurfurylidene)amino]-2-imidazolidinone; norlestrint; N-(9-oxo-2-fluorenyl) acetamide; phenacetint;
phenesterint; procarbazine.HCI*; propane sultone; sulfallate; 4,4-sulfonylbisacetanilide; toluene diiso-
cyanate, commercial grade (2,4 (80%)- and 2,6 (20%)-)t; o-toluidine.HCfT; 2,2,2-trifluoro-N-[4-(5-nitro-
2-furyl)-2-thiazolylJacetamidet; vinyl chloridet; FD & C Violet No.
lt
Mesovarium Rat 2 salbutamol; terbutaline
Myocardium Mouse 2 estradiol mustardt; phenesterint
Nasal cavityb Bush baby I N-nitrosodiethylamine
Hamster 10 acetaldehyde; diallylnitrosamine; dimethylcarbamyl chloride; hydrazinet; nitroso-2,6-dimethylmorpho-
line; N-nitrosoallyl-2-oxopropylamine; N-nitrosomethyl-2,3-dihydroxypropylamine; N-nitrosomorpho-
line; N-nitrosonornicotine; N-nitrosopiperidinet
Mouse 4 1,2-dibromo-3-chloropropanet; 1,2-dibromoethanet; formaldehydet; 1,2-propylene oxidet
Rat 33 acetaldehyde; acrylonitrile; benzenet; bis-(chloromethyl) ether:; p-cresidineT; diallylnitrosamine; 1,2-di-
bromo-3-chloropropanet; 1,2-dibromoethanet; dimethylvinyl chloridet; dinitrosohomopiperazine; 1,4-
dioxanet; Z-ethyl-O,N,N-azoxyethane; ethylnitrosocyanamide; formaldehydet; hydrazinet; N-nitroso-N-
methyldecylamine; di(N-nitroso)-perhydropyrimidine; N-nitroso(2,2,2-trifluoroethyl) ethylamine; 1-
nitroso-3,4,5-trimethylpiperazine; N-nitrosoallyl-2,3-dihydroxypropylamine; N-nitrosoallyl-2-hydroxy-
propylamine; N-nitrosoallylethanolamine; N-nitrosobis(2-hydroxypropyl) amine; N-nitrosobis(2-oxopro-
pyl) amine; N-nitrosodiethanolamine; N-nitrosodipropylamine; N-nitrosomethyl-2,3-dihydroxypropyl-
amine; N-nitrosomethyl-2-hydroxypropylamine; N-nitrosonornicotine- 1-N-oxide; phenacetint; phenyl-
glycidyl ether; 1,2-propylene oxidet; vinyl chloridet
Oralc Hamster 2 acetaldehyde; nitroso-2,6-dimethylmorpholine
cavity Monkey 1 N-nitroso-N-methylurea
Mouse 1 N-nitrosohexamethyleneimine
Rat 16 acrylamide; acrylonitrile;2-amino-3-methylimidazo[4,5-Aquinolinet; benzenet; 1,2-dibromo-3-chloro-
propanet; dimethylvinyl chloridet; dinitrosohomopiperazine; N-nitroso-2,3-dihydroxypnopyl-2-hydroxy-
propylamine; nitroso-2,3-dihydroxypropyl-2-oxopropylamine; nitroso-N-methyl-N-(2-phenyl) ethyl-
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amine; nitrosoamylurethan; N-nitrosodiethylamine; nitrosoheptamethyleneimine; 1-nitrosohydantoin;
N-nitrosothiomorpholine; 2,3,7,8-tetrachlorodibenzo-*pdioxint
Ovary Mouse 4 benzenet; 1,3-butadiene; 5-nitroacenaphthenet; 4-vinylcyclohexene
Pancreas Hamster 3 nitroso-2,3-dihydroxypropyl-2-oxopropylamine; nitroso-2,6-dimethylmorpholine; nitroso-2-oxopropyl-
ethanolamine
Monkey 2 aflatoxin Bit; methylazoxymethanol acetate and cycasin mixture
Rat 9 2-amino-3-methylimidazo[4,5-Jquinoline.HCl; azaserine; chlorendic acidt; cinnamyl anthranilatet;
clofibrate; ethyl alcohol; N-(N-methyl-N-nitrosocarbamoyl)-l-ornithine; nitrofent; toluene diisocyanate,
commercial grade (2,4 (80%)- and 2,6 (20%)_)t,d
Peritoneal cavitye Mouse 7 bis-1,2-(chloromethoxy) ethane; bis-1,4-(chloromethoxy)-p-xylene; bis-(chloromethyl) ethert; trans-1,4-
dichlorobutene-2; dimethylcarbamyl chloride; phenoxybenzamine.HC1t; tris-1,2,3-(chloromethoxy) pro-
pane
Rat 17 acronycine; acrylamide; actinomycin D; aniline.HClt; bromate, potassiumt; chlorozotocin; cytembenaf;
dapsonet; 1,2-dibromoethanet; dibromomannitolt; ethylene oxide; melphalant; N-methyl-N,4-dinitroso-
aniline; mitomycin-C; N-nitroso-2,2,4-trimethyl-1,2-dihydroquinoline polymer; phenoxybenz-
amine.HCAt; o-toluidine.HClt
Pituitary Mouse 4 enovid; norlestrint; propylthiouracilt; zearalenonet
gland Rat 7 acrylamide; 3-aminotriazolet; 1,2-dibromoethanet; diethylstilbestrolt; ethyl alcohol; metronidazolet;
norlestrint
Preputial gland Mouse 7 acetaldehyde methylformylhydrazone; benzenet; N-N-butyl-N-formylhydrazine; dimethylvinyl chloridet;
N-ethyl-N-formylhydrazine; N-N-propyl-N-formylhydrazine; thio-TEPAt
Rat 2 2,4-diaminoanisole sulfatet; isophoronet
Prostate Rat 2 N-nitrosobis(2-hydroxypropyl) amine; N-nitrosobis(2-oxopropyl) amine
Skin Hamster 2 urethanet; vinyl chloridet
Mouse 1 thio-TEPAt
Rat 20 2-acetylaminofluorenet; 3-amino-9-ethylcarbazole.HClt; 2-amino-3-methylimidazo[4,5-Aquinolinet; ben-
zenet; carboxymethylnitrosourea; 2,4-diaminoanisole sulfatet; dibromodulcitolt; dibromomannitolt; di-
methoxane; 2,5-dimethoxy-4'-aminostilbenet; 3,3'-dimethoxybenzidine-4,4'-diisocyanatet; dimethylvinyl
chloridet; lasiocarpine; N-(N-methyl-N-nitrosocarbamoyl)-I-ornithine; 5-nitro-*oanisidinet; p-ros-
aniline.HC1A; thio-TEPAt; thioureat; vinyl chloridet; FD & C Violet No. It
Small Monkey 2 methylazoxymethanol acetate and cycasin mixture; urethanet
intestine Mouse 3 captafol; N-ethyl-N-nitro-N-nitrosoguanidine; hydrogen peroxide
Rat 21 acrylonitrile; 3-amino-l-methyl-5H-pyrido[4,3-b]indole acetatet; 2-amino-6-methyldipyrido[ 1,2-a:3',2'-
dlimidazolet; 2-amino-3-methylimidazo[4,5-Jquinolinet; 2-aminodipyrido[1,2-a:3',2'-dlimidazolet; 4-bis-
(2-hydroxyethyl)amino-2-(5-nitro-2-thienyl) quinazoline; carboxymethylnitrosourea; 1-(4-chlorophenyl)-
l-phenyl-2-propynyl carbamate; 2,5-dimethoxy-4'-aminostilbenet; 4,6-dimethyl-2-(5-nitro-2-furyl)
pyrimidine; trans-2-[(dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4- oxadiazole; Z-
ethyl-O,N,N-azoxymethane; I-ethyl-I-nitrosourea; formic acid 2-[4-(5-nitro-2-furyl)-2-thia-
zolylihydrazidet; lasiocarpine; N-methyl-N-nitro-N-nitrosoguanidine; N-[5-(5-nitro-2-furyl)-1,3,4-thiadi-
azol- 2-yl]acetamidet; N-nitroso-N-isobutylurea; nitrosoethylurethan; propane sultone; quercetint
Spleen Rat 6 aniline.HCIt; azobenzenet; dapsonet; o-nitrosotoluene; D & C Red No. 9t; o-toluidine.HCft
Stomach Hamster 15 AF-2t; 1,4-dinitroso-2,6-dimethylpiperazine; formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazidet;
hydrazinet; N-hydroxy-2-acetylaminofluorenet; N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide; N-[4-(5-
nitro-2-furyl)-2-thiazolyl]formamidet; N-nitroso-2,3-dihydroxypropyl-2-hydroxypropylamine; nitroso-
2,3-dihydroxypropyl-2-oxopropylamine; nitroso-5-methyloxazolidone; N-nitroso-N-methylurethan; N-
nitroso-1,3-oxazolidine; 1-nitroso-3,4,5-trimethylpiperazine; urethanet; vinyl chloridet
Mouse 42 acetaldehyde methylformylhydrazone; AF-2t; 2-amino-3,4-dimethylimidazo[4,5-fjquinoline; 2-amino-3-
methylimidazo[4,5-1Jquinolinet; 2-amino-4-(5-nitro-2-furyl) thiazolet; trans-5-amino-3[2-(5-nitro-2-
furyl)vinyl-1,2,4-oxadiazole; arecoline.HC/; benzyl acetatet; benzyl chloridet; bromoethanol; 1,3-
butadiene; 1,l-di-N-butylhydrazine; captafol; carbazole; 3-chloro-2-methylpropene, technical grade (con-
taining 5% dimethylvinyl chloride)t; 3-(chloromethyl)pyridine.HCI; 2-chloropropanal; 1-chloropropene;
Ij-diallylhydrazine; 1,2-dibromo-3-chloropropane; 1,2-dibromoethanet; diglycidyl resorcinol ether,
technical gradet; dimethylvinyl chloridet; dinitrosopiperazine; estradiol mustardt; ethyl acrylatet;
formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazidet; 2-hydrazino-4-(5-nitro-2-furyl) thiazolet; N-
hydroxy-2-acetylaminofluorenet; 1-methyl-1,4-dihydro-7-[2-(5-nitrofuryl)vinyl]-4-oxo-1,8-naphthyridine-
3-carboxylate, potassium; 3-(5-nitro-2-furyl)-imidazo(1,2-a)pyridinet; N-[5-(5-nitro-2-furyl)-l ,3,4-thiadi-
azol-2-yllacetamidet; N-[4-(5-nitro-2-furyl)-2-thiazolyllformamidet; nitrosodibutylamine; N-nitroso-
hexamethyleneimine; N-nitrosopiperidinet; ,8-propiolactonet; styrene oxidet; Telone IIt; 2,2,2-trifluoro-
N-[4-(5-nitro-2-furyl)-2-thiazolyllacetamidet; trifluralint; tris(2,3-dibromopropyl) phosphatet
(Continued on next page)
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Rat 60 acetone[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazone; Y-acetoxysafrolet; acrylonitrile; 2-amino-5-(5-nitro-2-
furyl)-1,3,4-oxadiazole; 2-amino-545-nitro-2-furyl)-1,3,4-thiadiazole; 2-amino-4-(5-nitro-2-furyl) thia-
zolet; l-amyl-l-nitrosourea; benzenet; benzo(a)pyrenet; N-N-butyl-N-nitrosourea; butylated hydroxyan-
isole; ,#-butyrolactone; 3-chloro-2-methylpropene, technical grade (containing 5% dimethylvinyl
chloride)t; 4-chloro-o-phenylenediaminet; 34chloromethyl)pyridine.HC/t; cupferront; 1,2-dibromo-3-
chloropropanet; 1,2-dibromoethanet; 1,2-dichloroethanet; diglycidyl resorcinol ether, technical gradet;
2,5-dimethoxy-4'-aminostilbenet; dimethyl hydrogen phosphitet; 4,6-dimethyl-2-(5-nitro-2-furyl)
pyrimidine; trans-2-[(dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazole; di-
methylvinyl chloridet; epichlorohydrinT; ethyl acrylatet; ethylene oxide; fluorocarbon 31; 1-(2-hydroxy-
ethyl)-l-nitrosourea; I'-hydroxysafrolet; N-methyl-N-nitro-N-nitrosoguanidine; N-methyl-N-nitrosobenz-
amide; methylnitrosocyanamide; 3-(5-nitro-2-furyl)-imidazo(1,2-a)pyridinet; N-[5-(5-nitro-2-furyl)-
1,3,4-thiadiazol-2-ylJacetamidet; 4-(5-nitro-2-furyl) thiazole; 8-nitroquinoline; nitroso-Baygon; N-
nitroso-2,3-dihydroxypropyl-2-hydroxypropylamine; nitroso-2,3-dihydroxypropyl-2-oxopropylamine; 1-
nitroso-3,5-dimethyl-4-benzoylpiperazine; N-nitroso-N-methyl-N-dodecylamine; nitroso-N-methyl-N-(2-
phenyl) ethylamine; N-nitroso-N-methyldecylamine; nitroso-1,2,3,6-tetrahydropyridine; N-nitrosobenz-
thiazuron; nitrosodibutylaminet; N-nitrosodiethylamine; N-nitrosoephedrine; nitrosoethylurethan; phen-
acetint; pivalolactonet; 0-propiolactonet; N-propyl-N-nitro-N-nitrosoguanidine; 1,2-propylene oxidet;











Rat 10 2,4-diaminotoluene.2HClt; 1,2-dichloroethanet; dimethoxane; 4,4'-methylene-bis(2-methylaniline); o-
nitrosotoluene; prosaniline.HC/t; toluene diisocyanate, commercial grade (2,4 (80%)- and 2,6 (20%)-)t; o-toluidine.HClr;2,4,5-trimethylaniline.HC[t; 2,5-xylidine.HC1t
Mouse 1 reserpinet
Rat 6 N-butyl-N-(4-hydroxybutyl) nitrosamine; fluorocarbon 133a; metronidazolet; N-nitrosodimethylaminet;
trichloroethylenet; vinyl chloridet
Hamster 4 hexachlorobenzenet; hydrazinet; methylthiouracil; urethanet
Mouse 10 3-amino-4-ethoxyacetanilidet; HC Blue No. It; chlorinated paraffins (C12, 60% chlorine)t; 2,4-diamino-
anisole sulfatet; ethionamidet; 4,4'-methylenedianiline.2HCIt; 1,5-naphthalenediaminet; 4,4'-oxydi-
anilinet; 2,3,7,8-tetrachlorodibenzo-p-dioxint; 4,4'-thiodianilinet
Rat 20 3-aminotriazolet; o-anisidine.HClA; chlorinated paraffins (Cl2, 60% chlorine)t; 2,4-diaminoanisole
sulfatet; N,N-diethylthioureat; l-ethyl-l-nitrosourea; ethylene thioureat; methimazole; 4,4'-methylene-
bis(N,N-dimethyl) benzenaminet; 4,4'-methylenedianiline.2HClt; mirex, photo-; N-nitrosobis(2-oxopro-
pyl) amine; 4,4'-oxydianilinet; propylthiouracilt; p-rosaniline.HC!t; 2,3,7,8-tetrachlorodibenzo-p-dioxint;
4,4:thiodianilinet; trimethylthioureat; vinyl acetate; zinc dimethyldithiocarbamatet
Dog 2 3,3'-dichlorobenzidine; 4,4'-methylene-bis(2-chloroaniline)
Hamster 3 formic acid 2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide-; N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide;
N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamidet
Monkey 1 2-naphthylaminet
Mouse 12 2-acetylaminofluorenet; 4-aminodiphenyl; 4-aminodiphenyl.HC1t; 2-aminodiphenylene oxide; o-
anisidine.HClt; 4-chloro-4'-aminodiphenylethert; p-cresidinet; 4-ethylsulphonylnaphthalene-l-sulfon-
amide; N-hydroxy-2-acetylaminofluoreneT; N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamidet; phenacetint;
Telone Ilt
Rat 37 acetaminophent; allyl isothiocyanatet; 2-amino-3-methylimidazo[4,5-Aquinoline.HCI; 2-amino-4-(5-
nitro-2-furyl)thiazolet; 4-amino-2-nitrophenolt; 1 1-aminoundecanoic acidt; o-anisidine.HCIt; C.I.
Disperse Blue It; N-butyl-N-(4-hydroxybutyl) nitrosamine; 4-chloro-*ophenylenediaminet; m-cresidinet;
p-cresidinet; cyclophosphamidet; diethylene glycol; melaminet; 2-methoxy-3-aminodibenzofuran; 2-
naphthylamine; nitrilotriacetic acidt; nitrilotriacetic acid, trisodium salt, monohydratet; N-[4-(5-nitro-
2_furyl)-2-thiazolyl]formamidet; N-nitroso-N-methyl-N-dodecylamine; N-nitroso-N-methyl-N-tetradecyl-
amine; N-nitroso-N-methyldecylamine; N-nitrosobis(2-oxopropyl) amine; nitrosodibutylaminet; N-
nitrosodiphenylaminet; o-nitrosotoluene; N-oxydiethylene thiocarbamyl-N-oxydiethylene sulfenamide;
phenacetint; phenazone; o-phenylphenate, sodiumt; o-phenylphenolt; quercetint; p-quinone dioximet;
saccharin, sodiumt; o-toluenesulfonamide; o-toluidine.HCAt
Mouse 5 dacarbazinet; 1,2-dichloroethanet; (N-6)-(methylnitroso) adenosine; procarbazine.HClt; trimethylphos-
phatet
Rat 11 3-amino-9-ethylcarbazole.HClt; dacarbazinet; daminozidet; 3,3-dimethoxybenzidine-4,4'-diisocyanatet;






3 1,2-dimethylhydrazine.2HCI; hexachlorobenzenet; vinyl chloridet
2 aflatoxin B1t; procarbazine.HCIt
47 N-acetyl-4-(hydroxymethyl) phenylhydrazine; 1-acetyl-2-phenylhydrazine; allylhydrazine.HCl; 2-amino-
3-methyl-9H-pyrido-[2,3-b]-indole; 2-amino-6-methyldipyrido[ 1,2-a:3',2-dlimidazolet; 2-amino-9H-py-
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Table 1. Continued.
Tissue Species N Chemical names
rido(2,3-b) indole; 4-aminodiphenyl.HC1t; 2-aminodipyrido[1,2-a:3',2-d]imidazolet; arecoline.HC1;
benzidine.2HCl; 2-biphenylamine.HClt; 1,3-butadiene; captafol; carbamyl hydrazine.HCI; 4-chloro-4-
aminodiphenylethert; l-chloro-4-nitrobenzenet; 5-chloro-*otoluidinet; 4-chloro-o-toluidine.HClt; cupfer-
ront; dacarbazinet; daminozidet; 2,4-diaminotoluene.2HC!A; 1,2-dibromoethanet; diftalone; 7,12-di-
methylbenz(a)anthracene; 1,1-dimethylhydrazine; 1,2-dimethylhydrazine.2HCl; N-ethyl-N-formylhydra-
zine; ethylhydrazine.HCI; Y-hydroxysafrolet; N-methyl-N-formylhydrazine; 2-methyl-l-nitroanthraquin-
onet; Michler's ketonet; 5-nitro->otoluidinet; nitrofent; N-pentylhydrazine.HCl; phenylethylhydrazine
sulfate; phenylhydrazine.HCl; sterigmatocystint; toluene diisocyanate, commercial grade (2,4 (80%)- and
2,6 (20%)-)t; o-toluidine.HC1t; 2,4,6-trichloroanilinet; 2,4,5-trimethylaniline.HC1t; 2,4,6-trimethyl-
aniline.HCIt; vinyl chloridet; vinylidene chloridetf; 2,5-xylidine.HClt
Rat 26 3-amino-I-methyl-5H-pyrido[4,3-b]indole acetatet; 2-amino-3-methylimidazo[4,5-Alquinoline.HCI; aniline.HC1t; azobenzenet; benzenetf; clivorine; cupferront; 1,2-dibromoethanet; 1,2-dichloroethanet;
4,6-dimethyl-2-(5-nitro-2-furyl) pyrimidine; Z-ethyl-O,N,N-azoxyethane; Z-ethyl-O,N,N-azoxymethane;
lasiocarpine; 4,4'-methylene-bis(2-chloroaniline); N-[5-(5-nitro-2-furyl)-1,3,4-thiadiazol-2-yl]acetamidet;
N-nitroso-(2-hydroxypropyl)-(2-hydroxyethyl) amine; nitroso-1,2,3,6-tetrahydropyridine; N-nitrosobis(2-
oxopropyl) amine; N-nitrosodimethylaminet; N-nitrosopyrrolidinet; petasitenine; sterigmatocystint;
symphytine; o-toluidine.HC[A; vinyl bromide; vinyl chloridet
tAdequately tested in both mice and rats, but positive in only one ofthem.
tPositive in both mice and rats.
aCortical adenomas were induced by these chemicals.
bNasal cavity includes tissues of the nose, nasal turbinates, paranasal sinuses and trachea. If the author used the term "respiratory
system" to define the above tissues without including lung and the bronchioles, it was included in this category.
cOral cavity includes tissues ofthe mouth, oropharynx, pharynx, and larynx.
dlslet-cell adenomas were induced in females and acinar cell adenomas were induced in males.
ePeritoneal cavity includes mesotheliomas seen in either multiple organs, peritoneal cavity, peritoneum, abdominal cavity or abdo-
men.
fVascular tumors were induced only in liver.
indicating that it has been tested in both rats and mice
and is positive in both species at some target site. Since
chloroform is also listed under kidney for mice, both
species have been shown to induce tumors at that site.
In contrast 1,4-dichlorobenzene is listed under kidney
for the rat with the same symbol t, indicating that it is
positive in the mouse as well, but it is not listed under
kidney for the mouse; therefore, kidney is not a target
inthemouse. Anotherexampleunderratkidneyischlo-
rothalonil which has the symbol t, indicatingthat it has
been tested in both rats and mice, but is positive only
in one ofthem: in this case, the rat. Forazoxymethane,
however, there is no superscript, indicating that it has
not been tested in the mouse. When a chemical is listed
with supersclipts, the information applies only to rats
and mice. Sometimes the superscripts appear for a
chemical listed under a different species; for example,
under thyroid gland for hamsters, urethane is listed
with the symbol t, indicating that the chemical is a
carcinogen in both rats and mice, but the superscript
does not apply to results in hamsters. In Table 1 under
thyroid gland, urethane is not listed for either rats or
mice, and therefore it is not a target organ for either
species.
While Table 1 provides an exhaustive overview by
target site ofthe CPDB, full details on each experiment
are given in our published plots, including references
to the published papers, results ofnegative tests, and
the sex and strain in each test. The four plots of the
CPDB analyze the results ofpublished papers chrono-
logically, and appear in Environmental Health Per-
spectives (1-4). Experiments of a given chemical may
appear in more than one plot, and the reader can locate
all tests by referring to Appendix 14 in reference (4).
This appendixlists all 1052 chemicalsthatappearinany
of the four plots, indicating which plot(s) contains re-
sults on each chemical; the appendix is ordered alpha-
beticallybychemicalnameandcommonsynonym. Thus,
for any target organ of interest, using Table 1 in con-
junction with the published plots ofthe CPDB will pro-
vide detailed information on each experiment (see "In-
troduction"). For example, the CPDB includes
experiments of 96 mouse strains and 71 rat strains. A
combined plot ofthe entire CPDB, that merges results
from all four plots and is organized by chemical, can be
obtained from the first author. A computer readable
(SAS) database is also obtainable.
Based on Table 1, the frequency of carcinogenic re-
sponse by site in rats and mice is tabulated in Table 2.
Twenty-eight sites are identified as positive target or-
gans in the mouse and 31 in the rat. In both species,
the liver is the most common target site, and it is the
predominant site in the mouse. The second most com-
mon sites are the mouse lung and the rat mammary
gland. In the subset ofNCI/NTP bioassays, which use
anextensive andstandardizedpathologyprotocol, these
same sites are the most frequent in each species, al-
though the rat stomachis identified asfrequentlyasthe
rat mammary gland. Chemical carcinogens thus induce
tumors in a wide variety oftarget organs. As shown in
Table 2, each ofeight sites is a target for at least 10%
of the carcinogens in either rats or mice: liver, lung,
mammarygland, stomach, vascularsystem, kidney, he-
matopoietic system, and urinary bladder.
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Table 2. Frequency of positive target sites for chemicals
classified as positive by author's opinion.
Number positive at site (%)'
Chemicals evaluated as Chemicals evaluated as
carcinogenic in rats carcinogenic in mice
(n = 354)b (n = 299)b
Liver 143 (40%) 171 (57%)
Lung 31 (9%) 83 (28%)
Mammary gland 73 (21%) 14 (5%)
Stomach 60 (17%) 42 (14%)
Vascular system 26 (7%) 47 (16%)
Kidney/ureter 45 (13%) 12 (4%)
Hematopoietic
system 35 (10%) 39 (13%)
Urinary bladder/
urethra 37 (10%) 12 (4%)
Nasal cavity/
turbinates 33 (9%) 4 (1%)
Ear/Zymbal's gland 30 (9%) 2
Esophagus 29 (8%) 7 (2%)
Small intestine 21 (6%) 3 (1%)
Thyroid gland 20 (6%) 10 (3%)
Skin 20 (6%) 1
Peritoneal cavity 17 (5%) 7 (2%)
Oral cavity 16 (5%) 1
Large intestine 15 (4%)
Central nervous
system 15 (4%) 2
Uterus 11 (3%) 5 (2%)
Subcutaneous tissue 10 (3%) 1
Pancreas 9 (3%)
Adrenal gland 7 (2%) 4 (1%)
Pituitary gland 7 (2%) 4 (1%)
Clitoral gland 7 (2%) 2
Preputial gland 2 7 (2%)
Testes 6 (2%) 1
Harderian gland 6 (2%)
Spleen 6 (2%)
Ovary 4 (1%)






aPercentages are not given when fewer than 1% ofthe carcinogens
were active at a given site.
bChemicals have been excluded for which the only positive results
in the CPDB are for "all tumor bearing animals," i.e., there is no
reported target site.
Multiple Target Sites for a Chemical
It is common for a chemical to induce tumors at more
than one site in a species. This is demonstrated in Table
2 where the summation ofthe percentages ofchemicals
that are positive in the various organs for each species
is far greater than 100%. Table 2 also indicates that in
rats compared to mice, a larger number of organs are
target sites for a higher percentage ofthe carcinogens,
e.g., in rats each of16 sites is atarget organ for at least
5% of the compounds compared to only six sites in the
mouse.
Overall, in rats, 176 of 328 carcinogens (54%) cause
tumors at multiple sites; for mice, 43% (122/283) are
multiple-site carcinogens. Fewerchemicals areincluded
in this analysis than are shown in Table 2 because mul-
tiple-site carcinogenesis cannot be measured for exper-
imentsthatrestricthistopathological examinationorre-
port data for only a few selected tissues. Although we
havedefinedmultiple-sitecarcinogenesis inthisanalysis
as target sites in any ofthe experiments on a chemical
(multiple sites across experiments), the results are sim-
ilar ifmultiple-site carcinogen is defined as two or more
target organs within a single experiment (at least one
experiment of the chemical has two or more target
sites): in rats, 51% (167/328) are multiple-site carcino-
gens, and in mice 39% (109/283).
The liver is the most frequent target site in both
species and the predominant site in the mouse (Tables
1 and 2). We have investigated whether the pattern of
single versus multiple-site carcinogenesis in the mouse
isunusualforlivercarcinogens compared tothe pattern
forothermouse carcinogens orforrat carcinogens. Fig-
ure 1 shows the distribution ofcarcinogens in each spe-
cies by whether or not they are positive in the liver at
all, andwhetherthereis onlyonetargetsite, twotarget
sites, or three or more. The pattern oftarget sites dif-
fers in the two species. Overall, fewer carcinogens in
themousethantherataremultiple-site andmanyfewer
in the mouse have three or more target organs. How-
ever, this difference between species is not due to the
frequency of single-site carcinogenesis in the mouse
liver. Figure 1 indicatesthatinthemousethefrequency
ofsingle-site carcinogenesis is similarforchemicalsthat
are positive in the liver and for mouse carcinogens that
are positive only at other sites. In rats, however, liver
carcinogens are most often multiple-site carcinogens,
andparticularlyaremoreoftenpositiveatthreeormore
target sites, whereas the pattern ofsingle-site carcino-
genesis among chemicals that are positive only at sites
otherthan the liveris similar to the mouse carcinogens.
Thus, there is a similar distribution of single-site car-
cinogenesis for mouse liver carcinogens, other mouse
carcinogens, and rat carcinogens that are positive only
at sites other than the liver. In comparison, rat liver
carcinogens are more frequently positive at multiple
sites. Similar results are obtained for NCI/NTP bioas-
says alone and for the subset ofchemicals that are pos-
itive in both rats and mice.
Despite the wide variety of target organs in each
species, due to the frequency of multiple-site carcino-
genesis, most carcinogens in rats and mice can be iden-
tified by just the eight most common sites: liver, lung,
mammarygland, stomach, vascularsystem, kidney, he-
matopoietic system, and urinary bladder. Overall, 94%
(266/283) ofmouse carcinogens and 83% (273/328) ofrat
carcinogens are positive in at least one of these eight
sites. The chemicals that do not induce tumors in one
ofthese sites are primarily single-site carcinogens that
are positive only in a less common target organ; there
are more ofsuch chemicals in ratsthan inmice, and this
explains the lower percentage of rat carcinogens that
are identified by the top eight sites.










Positive in Liver Positive, Not in Liver
Rats (N = 328, 100%)
E I a 2 * .3
Number ofTarget Sites Per Carcinogen
FIGURE 1. Distribution of carcinogens by number of target sites in rats and mice.
Prediction of Carcinogenicity and
Target Organ, from Rats to Mice
and from Mice to Rats for
Chemicals Tested in Both Species
Results from rodent bioassays are often used to pre-
dictwhether achemicalis apotentialhumancarcinogen.
Ideally, one would like to know the accuracy ofpredic-
tion from rats or mice to humans, but because epide-
miologic data are usually lacking and experiments can-
not be conducted in humans, this knowledge is not
available. Data are available, however, on the accuracy
of prediction between the two closely related species,
rats and mice. These datareflectresults obtained under
similar experimental conditions, including administra-
tion of estimated maximum tolerated doses (MTD) and
laboratory diets fed ad libitum. Thus, qualitative pre-
diction from one rodent species to another (prediction
ofpositivity and prediction oftarget organ) can be ex-
amined without simultaneously having to address the
issue of high to low dose extrapolation (5). One would
expect that prediction of positivity and target organ
from rats to mice tested under similarconditions, would
be at least as good, and likely much better than pre-
diction from rats or mice to humans exposed at much
lower doses.
Table 3 reports the comparison of carcinogenic re-
sponse in rats and mice for 427 chemicals tested in both
species. Overall, prediction from rats to mice indicates
Table 3. Comparison of carcinogenic response for 427 chemicals
tested in both rats and mice.
Not positive in either rats or mice 172
Positive in rats only 46
Positive in mice only 61
Positive in both rats and mice, no common target site 47
Positive in both rats and mice at same target site ioia
aFor 56 of these 101 chemicals there is a site other than the liver
in common between rats and mice.
that 194 chemicals (46+47+ 101) are carcinogenic in
rats, and 148 (47+101) ofthe 194 are also carcinogenic
in mice: 76%. The predictive value from mice to rats is
similar. Ofthe209chemicals (61 +47+101) carcinogenic
inmice, 148(47+101) arealsocarcinogenicinrats: 71%.
Predictionisless accurate fromtarget sitetotargetsite
because some chemicals are positive only at different
sites in the two species. Among 194 rat carcinogens,
24% (46) are negative in mice, 24% (47) are positive in
mice but only at a different target site, and 52% (101)
are positive at the same site; the corresponding values
for predicting from mice to rats among the 209 mouse
carcinogens are 29% (61) negative in rats, 22% (47) pos-
itive only at a different site, and 48% (101) positive at
the same site.
To investigate how well a carcinogenic response at a
particular site in one species predicts carcinogenicity in
a second species, we have examined results in rats and
mice for 10frequent sitesthataretargetsformorethan
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15 carcinogens in either the rat or the mouse (Table 4).
The analysis is based on the 255 chemicals that have
been tested in both species and are reported in Table 3
as positive, in either orboth species (46+61 +47+101).
Table 4 is an update ofwork we published earlier for a
smaller number of compounds (5), and reports a) the
number of carcinogens at each of 10 frequent sites in
rats or mice; for each site, we also give b) the number
and proportion that are positive at some site in the
second species, and c the number that are positive at
the same site in both species. Most individual sites are
good predictors of carcinogenicity at some site in the
other species. The least accurate predictors are the uri-
nary bladder in the rat (48%) and the liverin the mouse
(65%).
Table 4 also indicates that there is a wide range in
the predictive value ofcarcinogenicity to the same site
in the other species: for the two most frequent sites in
the mouse 56 ofthe 131 mouse liver carcinogens (43%)
are positive in the rat liver, and only 8/45 (18%) mouse
lung carcinogens are positive in the rat lung. For the
two most frequent sites in the rat, 56 ofthe 79 rat liver
carcinogens (71%) are positive in the mouse liver, and
only 5/35 (14%) rat mammary gland carcinogens are
positive in the mouse mammary gland. These results
are similar to those we discussed earlier (5). Amongthe
101 chemicals with a site in common between rats and
mice, 56 are positive in the liver of both species. We
examined these 56 in detail and found that 11 had an
additional site in common. Thus, for45 ofthe 101 chem-
icals the one site in common is the liver, and for 56
chemicals there is at least one different site in common.
Discussion
This paper presents both a compendium of bioassay
results organized by target site, and analyses oftarget
site in rats and mice. We have shown some similarities
intheresultsforthe two species: thereis awide variety
of target sites in both the rat and the mouse; the liver
is the most common site in both species; and more than
80% of the carcinogens in each species are positive in
at least one ofthe eight most frequent sites: liver, lung,
mammarygland, stomach, vascular system, kidney, he-
matopoietic system, and urinary bladder. We have also
shown some differences in the results for the two spe-
cies: a chemical is more likely to induce tumors at two
or more sites in rats than in mice; and some sites are
frequent targets in one species and not the other, e.g.,
mammary gland, Zymbal's gland, and skin in the rat.
The liver is the most frequent site in both rats and
mice. In mice, it is the predominant site. In an earlier
paper (5) we showed for chemicals that were tested in
both rats and mice that: a) when results in both species
are taken into account, there are relatively few rodent
carcinogens that are positive only in the mouse liver
and not in either another mouse site or at all in the rat
(14%) (termed "single-site mouse liver carcinogens");
and b) excluding chlorinated compounds, the single-site
mouse liver carcinogens do not differ from other mouse
liver carcinogens in the frequency with which they are
mutagenic in Salmonella (5). In this paper, we have
shown that carcinogens in the mouse liver are similar
to mouse carcinogens that are not positive in the liver,
in terms ofhow frequently there is only a single target
site. In rats there is a similar pattern forchemicals that
are not positive inthe liver. In comparison, carcinogens
that affect the rat liver also commonly affect another
site (Fig. 1). These results are consistent with our ear-
lier findings (5).
Rats and mice are two closely related species that
are studied under similar experimental conditions; in
particular, both receive doses at or near the MTD for
the species. In comparison, humans are less closely re-
Table 4. Predictive value of target sites in one species for carcinogenicity in a second species: rats and mice.
Chemicals tested in both rats and mice and evaluated as positive in at least one experiment.
Rats Mice
Number positive Number positive
at site in rats at site in mice
Total number that are also Total number that are also Number positive
positive at positive at some positive at positive at some at same site in
Target sitea siteb site in mice site site in rats rat and mouse
Liver 79 70 (89%) 131 85 (65%) 56
Lung 16 14 (88%) 45 38 (84%) 8
Mammary gland 35 32 (91%) 9 8 (89%) 5
Stomach 29 25 (86%) 27 23 (85%) 14
Hematopoietic system 18 12 (67%) 29 24 (83%) 8
Vascular system 13 11 (85%) 27 20 (74%) 5
Kidney/ureter 26 18 (69%) 11 9 (82%) 7
Urinary bladder/urethra 25 12 (48%) 9 9 (100%) 4
Ear/Zymbal's gland 18 18 (100%) 2 2 (100%) 2
Skin 16 13 (81%) 1 1 (100%) 1
At leasts one sitec 194 148 (76%) 209 148 (71%) 101
aTarget sites reported in the table are those affected by more than 15 chemicals in at least one species.
bNumbers add to more than total for "at least one site" because there is often more than one target site per chemical per species.
cIncludes all target sites, including those not shown in this table.
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lated to rodents, and the levels ofhuman exposure are
usually orders ofmagnitude lowerthanthe MTD. Thus,
there may be qualitative as well as quantitative species
differences between humans and either rats or mice.
The practice ofextrapolating rodent results to humans
should be judged by the accuracy of extrapolation be-
tween rodent species, since the predictive value from a
rodentspecies tohumanswouldbeexpected tobe lower
thanthat betweentworodent species atthe MTD (5,8).
We have shown above and previously (5) that it cannot
be assumed that a chemical positive in rats will be pos-
itive at the same site in the mouse, or visa versa. Over-
all, knowing that a chemical is positive in one of the
species predicts positivity at some site inthe other spe-
cies about 75% of the time. This result is similar to
results reported earlier for smaller numbers of chemi-
cals (5,8-10). The overall predictive values between
rats and mice provide some confidence in interspecies




Site-specific prediction between rats and mice is less
accurate than overall prediction ofpositivity. Knowing
that a chemical is positive at any site in one species
gives about a 50% chance that it will be positive at the
same site in the other species. Since many chemicals
induce tumors atmultiplesites, thereisoftenmorethan
one target site that is potentially a common site for the
two species. Among the 101 chemicals with a site in
common, 56 have a common site other than the liver.
In order to examine further the issue ofsimilarity of
target sites between species, we have also compared
results for the limited number of compounds tested in
hamsters and rats, or hamsters and mice. Prediction
from rats to hamsters or from mice to hamsters is sim-
ilar to, but slightly less accurate than, prediction be-
tween rats and mice. Overall, 64% (21/33) ofrat carcin-
ogensarepositiveinhamsters, and61%(17/28)ofmouse
carcinogens are positive in hamsters. Knowing that a
chemical is positive at a specific site in the rat gives a
45% chance that it will be positive in the same site in
the hamster, and for mouse to hamster the chance is
48%.
Ultimately, one wants to know whether chemicals
thathavebeenshowntobecarcinogenicinexperimental
animals are also carcinogenic in humans. This question
cannot be answered by reversing the question (i.e., by
asking whether chemicals that are human carcinogens
are also carcinogenic in a rodent species) because even
ifmost human carcinogens are rodent carcinogens, the
converse does not necessarily follow, as can be dem-
onstratedbyasimpleprobabilisticargument (11). How-
ever, some additional evidence about interspecies ex-
trapolation can be obtained byaskinghowgood amodel
the human is forthe rat orthe mouse, even though this
willnotprovide directevidence about howgood amodel
the rat or mouse is for the human. The evaluations of
the IARC list 53 known human carcinogens including
industrial processes, therapeutic combinations, single
chemicals, and mixtures such as tobacco smoke (6,7,
12). For 33 ofthese, data in experimental animals have
been evaluated by IARC (12). The CPDB includes only
results of experiments on single chemicals, adminis-
tered by routes expected to result in whole body ex-
posure, thatmeetspecifiedexperimental-design criteria
(described in "Methods"). A search of the CPDB indi-
catesthatresultsareincludedfor 16humancarcinogens
tested in rats, and for 13 tested in mice. Using only
these CPDB results, the overall predictive value from
humans to rats is 75% (12/16) and from humans to mice
is 77% (10/13). For some human carcinogens with only
negative results in the CPDB, positive results have
been obtained in experiments not meeting CPDB inclu-
sion criteria (7).* Prediction based on target organ is
44% (7/16) from humans to rats and 31% (4/13) from
humansto mice. Thus, the overall predictive values are
similar to those reported above between rats and mice
for the CPDB; the value for target organ is slightly
lower for mice.
Based on this experimental evidence from the CPDB
involvingprediction fromratstomice, fromratsormice
to hamsters, and from humans to rats or mice, we con-
clude that one cannot assume that ifa chemical induces
tumors at a given site in one species it will also induce
tumors at the same site in a second species; the likeli-
hood is at most 52%.
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